TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Xellia Pharmaceuticals ApS
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,599,382
|
1,986,816
|
2,245,303 |
| Earnings before taxes |
973,573
|
-2,128,062
|
-254,602 |
| Total assets |
3,200,468
|
2,105,002
|
3,460,247 |
| Current assets |
1,396,228
|
1,322,677
|
1,070,897 |
| Current liabilities |
2,399,530
|
2,043,268
|
1,095,429 |
| Equity capital |
162,454
|
-597,775
|
1,750,675 |
| - share capital |
201,000
|
201,000
|
201,000 |
| Employees (average) |
750
|
350
|
350 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
5.1%
|
-28.4%
|
50.6% |
| Turnover per employee |
2,133
|
5,677
|
6,415 |
| Profit as a percentage of turnover |
60.9%
|
-107.1%
|
-11.3% |
| Return on assets (ROA) | |||
| Current ratio |
58.2%
|
64.7%
|
97.8% |
| Return on equity (ROE) |
599.3%
|
356.0%
|
-14.5% |
| Change turnover |
-387,434
|
-258,487
|
452,677 |
| Change turnover % |
-20%
|
-12%
|
25% |
| Chg. No. of employees |
400
|
0
|
0 |
| Chg. No. of employees % |
114%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.